Clinical Development Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Clinical Development stocks.

Clinical Development Stocks Recent News

Date Stock Title
May 20 ICLR ICON plc to hold Investor Day Meeting on May 30, 2024
May 18 AXSM 3 Monster Stocks in the Making You Can Buy Right Now
May 17 FBIO Fortress Biotech files for $50M mixed shelf
May 17 MEDP Haemonetics Stock Up 10.9% YTD: Will the Rally Continue?
May 17 CYTK Cytokinetics CEO Blum says positioned to market heart drug aficamten by itself
May 17 ICLR Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
May 17 CYTK Cytokinetics Hosts Muscle Biology-Focused Research Symposium: Contemporary Landscapes in Muscle Biology
May 16 FBIO Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)
May 16 FBIO Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
May 15 FBIO Fortress Biotech GAAP EPS of -$1.03 beats by $0.70, revenue of $13M misses by $1.13M
May 15 FBIO Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
May 15 FBIO Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
May 15 FBIO AquaBounty Technologies, Inc. (AQB) Reports Q1 Loss, Misses Revenue Estimates
May 15 FBIO Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
May 15 CYTK Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2024
May 15 LIFE aTyr Pharma to Present Poster Describing Efzofitimod’s Mechanism of Action at the American Thoracic Society 2024 International Conference
May 14 MEDP Here's How Much You Would Have Made Owning Medpace Hldgs Stock In The Last 5 Years
May 14 FBIO Fortress Biotech Announces First Patient Dosed in Multi-Center Phase 2 Study of Triplex for Control of CMV in Patients Undergoing Liver Transplantation
May 14 LIFE aTyr Pharma Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
May 14 LXRX New Post-Hoc Analysis of Pooled Phase 3 Data Shows That INPEFA® (Sotagliflozin) Reduced Risk of Heart Failure Events in Patients With Preserved Ejection Fraction
Clinical Development

Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.

Browse All Tags